Amylx Pharmaceuticals Inc vs Commvault Systems Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B), while Commvault Systems Inc trades at $139.62 (market cap $5.78B). The key difference: Commvault Systems Inc is far larger — about 2.2× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Commvault Systems Inc nearer its low. Which is the better fit depends on your goals.
| AMLX | CVLT | |
|---|---|---|
Market Cap | $2.64B | $5.78B |
Sector | Health | Technology |
52-Week High | $24.19 | $195.41 |
52-Week Low | $7.82 | $75.18 |
Enterprise Value | $2.39B | $5.76B |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Commvault provides enterprise-grade data protection and information management software. Its platform helps businesses manage, back up, and recover data across on-premises, cloud, and hybrid environments.
Read more on CVLT →